Bridge Laboratories will build a second preclinical facility in China, a 150,000 square foot facility that will be adjacent to Bridge's existing laboratory in the Zhongguancun Life Science Park in Beijing. Construction will begin in Q4 of 2008, and it should be completed in approximately one year. The new facility, which will be built to meet FDA and worldwide standards, will provide GLP toxicology, immunology, vaccine, and bioanalytical services. More details...